NURIX THERAPEUTICS, INC. (NRIX) Shareholders’ equity 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) shareholders’ equity at each fiscal year-end, per SEC filings.
$538.7MFY2025 · since FY2019: -$57.7M → $538.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $538.7M | +2.2% |
| FY2024 | $527.0M | +162.8% |
| FY2023 | $200.5M | -34.0% |
| FY2022 | $303.7M | -11.3% |
| FY2021 | $342.3M | +17.9% |
| FY2020 | $290.3M | +602.9% |
| FY2019 | -$57.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice